Label: SENNA-S- docusate sodium, sennosides tablet, film coated

  • NDC Code(s): 63561-0187-2
  • Packager: Granulation Technology, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 26, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

  • Active ingredients (in each tablet)

    Docusate Sodium         50 mg

    Sennosides                        8.6 mg

  • Purpose

    Stool softener

    Laxative

  • Uses

    • Relieves occasional constipation (irregularity)
    • Generally produces a bowel movement in 6-12 hours
  • Warnings

  • Do not use

    • If you are now taking mineral oil, unless directed by a doctor
    • Laxative products for longer than 1 week unless directed by a doctor
  • Ask a doctor before use if you have

    • Stomach pain
    • Nausea
    • Vomiting
    • Noticed a sudden change in bowel habits that continues over a period of 2 weeks
  • Stop using and ask a doctor if

    you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

  • If pregnant or breast-feeding,

    ask a health professional before use.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    • Take preferably at bedtime or as directed by a doctor
    agestarting dosagemaximum dosage
    adults and children
    12 years of age and over     		2 tablets once a day4 tablets twice a day
    children 6 to under 12 years1 tablet once a day2 tablets twice a day
    children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
    children under 2 yearsask a doctorask a doctor

  • Other information

    • Each tablet contains: Calcium 30 mg, Sodium 6 mg LOW SODIUM
    • Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)
  • Inactive ingredients

    croscarmellose sodium,dibasic calcium phosphate dihydrate, microcrystalline cellulose, pregelatinized starch, colloidal silicon dioxide, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol (PEG) 3350, talc, FD&C red 40 lake, FD&C yellow 5 lake

  • Principal Display Panel

    NDC 63561-0187-2

    Senna-S

    DOCUSATE SODIUM 50 mg / STOOL SOFTENER

    SENNOSIDES 8.6 mg / LAXATIVE

    Compare to Senokot-S ®Dual Action Active Ingredients

    220 Film-Coated Tablets

    Docusate Sodium 50 mg Sennosides 8.6 mg

    Docusate Sodium 50 mg Sennosides 8.6 mg_peel

  • INGREDIENTS AND APPEARANCE
    SENNA-S 
    docusate sodium, sennosides tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63561-0187
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    MICROCRYSTALLINE CELLULOSE 200 (UNII: 5XDI2TS1EZ)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    POLYVINYL ALCOHOL (UNII: 532B59J990)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)  
    TALC (UNII: 7SEV7J4R1U)  
    FD&C RED NO. 40 ALUMINUM LAKE (UNII: 6T47AS764T)  
    FD&C YELLOW NO. 5 ALUMINUM LAKE (UNII: JQ6BLH9FR7)  
    Product Characteristics
    ColororangeScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code G187
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:63561-0187-2220 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product11/26/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)11/26/2024
    Labeler - Granulation Technology, Inc. (847132193)
    Registrant - Granulation Technology, Inc. (847132193)
    Establishment
    NameAddressID/FEIBusiness Operations
    Granulation Technology, Inc.847132193manufacture(63561-0187)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!